v3.26.1
NOTE 6 - CONVERTIBLE NOTE PAYABLE (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Convertible Notes Payable, Current $ 542,256   $ 542,256   $ 102,072
Convertible notes payable, long-term, net of $880 and $0 debt discount, respectively 443,220   443,220   434,100
Convertible notes payable, current, net of $1,814,521 and $32,483 debt discount, respectively. $70,000 and $45,000 in default, respectively 542,256   542,256   102,072
Accrued interest payable 211,900   211,900   129,229
Convertible Notes Payable 985,476   985,476   536,172
Debt Instrument, Unamortized Discount, Current 1,814,521   1,814,521   32,483
Convertible Debt          
Interest Expense, Debt       $ 4,017  
Accrued interest payable         68,617
Convertible Note Payable          
Convertible notes payable, current, net of $1,814,521 and $32,483 debt discount, respectively. $70,000 and $45,000 in default, respectively 45,000   $ 45,000    
Equity Financing Description     The note, together with all unpaid accrued interest, is automatically convertible in full upon the closing of a qualified financing. A qualified financing is defined as an equity financing resulting in gross proceeds to the Company of at least $750,000, including the conversion of this note and other debt. Upon a qualified financing, the conversion price would be equal to 100% of the per-share price paid by investors in the financing, subject to valuation adjustments ranging from a minimum valuation of $15.0 million to a maximum valuation of $30.0 million. We reviewed this conversion feature under ASC 815 and determined no derivative accounting was required. See Note 9    
Convertible Notes Payable 45,000   $ 45,000   45,000
Series 2023 Convertible Notes          
Interest Expense, Debt 848 $ 854 1,686 1,694  
Accrued interest payable 10,235   10,235   8,549
Convertible Notes Payable 34,000   $ 34,000   34,000
Series 2025 Notes Mandatorily Convertible Notes          
Equity Financing Description     These notes are substantially similar to the Series 2023 Notes, except that they convert at 50% of the applicable offering price, or if the Company’s common stock trades at or above $1.00 ($0.50 for the March 18 Note) for 10 consecutive trading days, in which case they convert at 50% of the closing price on the tenth day    
Interest Expense, Debt 11,208 $ 9,340 $ 22,269 $ 9,574  
Accrued interest payable 53,937   53,937   31,668
Convertible Notes Payable 434,100   $ 434,100    
November 2025 Convertible Promissory Note          
Equity Financing Description     Beginning 180 days after issuance, the note is convertible at the option of the holder into shares of the Company’s common stock at a conversion price equal to 75% of the lowest volume-weighted average price (“VWAP”) of the Company’s common stock during the twenty (20) consecutive trading days immediately preceding the conversion date, subject to a floor price of $0.15 per share. Accrued and unpaid interest is convertible on the same terms. The note includes a beneficial ownership limitation of 4.99%, which may be increased to 9.99% upon advance notice. The November 2025 Convertible Promissory Note includes an embedded conversion feature that is accounted for as a derivative liability under ASC 815. See Note 9.    
Interest Expense, Debt     $ 4,269    
Accrued interest payable 5,548   5,548   1,279
Convertible Notes Payable 46,590   46,590   $ 23,072
Proceeds from issuance of convertible notes payable     50,000    
Debt discount at inception of derivative     29,647    
Debt Instrument, Unamortized Discount, Current 8,965   8,965    
Amortization of Debt Discount Recognized as Interest Expense     $ 23,517    
Series 2026 Notes Mandatorily Convertible Notes          
Equity Financing Description     During the six months ended June 30, 2026, the Company issued a new note for $10,000, denoted as Series 2026 Notes. These notes are identical to the Series 2025 Notes. The derivative liability was recognized at fair value of $1,000 on the issuance date and was recorded as a debt discount which is being amortized over the term of the note using the effective interest method. The derivative liability is subsequently remeasured at fair value at each reporting period, with changes in fair value recognized in the consolidated statement of operations. As of June 30, 2026, the derivative liability associated with this note is included in Derivative liabilities – convertible instruments on the consolidated balance sheet (see Note 9). As of June 30, 2026, the net carrying amount of this note was $9,120 and the debt discount was $880    
Interest Expense, Debt 357   $ 534    
Accrued interest payable $ 534   $ 534